CytomX Therapeutics (CTMX) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/06/21
CytomX Therapeutics Announces First Quarter 2021 Financial Results and Provides Business UpdateGlobeNewsWire • 05/06/21
CytomX Therapeutics to Announce First Quarter 2021 Financial Results on May 6, 2021GlobeNewsWire • 04/29/21
Co-Diagnostics, DocuSign, Dow, Nomura, Sea and More Monday Afternoon Analyst Calls24/7 Wall Street • 03/29/21
CytomX Therapeutics (CTMX) Upgraded to Buy: What Does It Mean for the Stock?Zacks Investment Research • 03/02/21
CytomX Therapeutics, Inc. (CTMX) CEO Sean McCarthy on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/25/21
CytomX Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business UpdateGlobeNewsWire • 02/24/21
CytomX Therapeutics to Present at Upcoming March Virtual Investor ConferencesGlobeNewsWire • 02/22/21
CytomX Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021GlobeNewsWire • 02/17/21
UPDATE - CytomX Therapeutics Announces Full Exercise of Underwriters' Option to Purchase Additional SharesGlobeNewsWire • 02/03/21
CytomX Therapeutics Announces Full Exercise of Underwriters' Option to Purchase Additional SharesGlobeNewsWire • 02/03/21
CytomX Therapeutics Announces Pricing of $100 Million Public Offering of Common StockGlobeNewsWire • 01/21/21
CytomX Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/07/21
CytomX Therapeutics, Inc. (CTMX) CEO Sean McCarthy on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/08/20
CytomX Therapeutics (CTMX) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/06/20
CytomX Therapeutics Announces Third Quarter 2020 Financial Results and Provides Business UpdateGlobeNewsWire • 11/05/20